ResCare Switches to ‘Home Health Lite’

by | Apr 12, 2017 8:35 pm | Home Health & Hospice

ResCare Inc., a portfolio company of Onex Corp. (TSE: ONEX), is changing the direction of its home health segment. ResCare, the nation’s largest private provider of services to people with disabilities, has been divesting its home health assets since 2014. A recent 10-K filing by Onex Corp. stated that ResCare was exiting the skilled line of business in the home care segment and transitioning to home health services without the skilled nursing. The exit resulted in a 2% decrease in revenue between 2015 and 2016, which was substantially offset by acquisitions within the home care and residential services segments, according to the filing. On April 10, 2017, Active Day/Senior Care... Read More »

Managed Care Deals Slide, Then Settle

by | Apr 7, 2017 5:54 pm | Managed Care

Mergers and acquisitions in the Managed Care sector had a good run back in 2015. Since then, it’s been slow going for deal makers. Following a hot streak of transactions in 2015, M&A activity didn’t just trail off in 2016, deal volume cratered—down 52%, to 21 transactions. The recent high of 43 deals announced in 2015 has been revised downward, and will be again by the end of the year. The mega-deals of 2015, announced between Aetna (NYSE: AET) and Humana (NYSE: HUM) at $37 billion, and Anthem (NYSE: ATHM) and Cigna (NYSE: CI) at $54.2 billion, have been blocked on antitrust grounds by two federal judges. In February 2017, Aetna and Humana called off... Read More »

DaVita Divests Seven Dialysis Clinics

by | Apr 7, 2017 3:49 pm | Laboratories, MRI & Dialysis, Private Equity

DaVita Inc. (NYSE: DVA) isn’t usually on the sell-side of dialysis deals. In fact, the company hasn’t announced a sale from its renal care division in the past five years. But in late March, the Federal Trade Commission ordered DaVita to divest its ownership in seven dialysis clinics. That order was part of a settlement resolving charges that DaVita’s $358 million acquisition of Renal Ventures Management, LLC would be anticompetitive. At the time of that deal’s announcement in August 2015, Renal Ventures operated 36 dialysis clinics in six states. The company’s two divisions, Multispecialty Physician Partners and Physician Venture Partners, operated infusion... Read More »

Sartorius AG Scores Two More Deals

by | Apr 7, 2017 3:10 pm | eHealth, Laboratories, MRI & Dialysis, Pharmaceuticals, Private Equity

Sartorius AG (FWB: SRT), a German pharmaceutical and laboratory equipment provider, has expanded with the acquisition of a medical device company and a digital health company for a combined total of $392.5 million. Sartorius operates through two divisions: bioprocess solutions and lab products & services. On March 3, 2017, Sartorius acquired privately-held Essen BioScience Inc. from SFW Capital Partners for $320 million. Essen develops and manufactures instruments, software, reagents and consumables which enable researchers to remotely image and quantify a wide variety of cellular processes over time. Through this acquisition, Sartorius significantly expands its portfolio for... Read More »
PE-backed Pivot Physical Therapy Grows (Again)

PE-backed Pivot Physical Therapy Grows (Again)

by | Apr 6, 2017 1:09 pm | Private Equity, Rehabilitation

Acquisitions of rehabilitation companies and clinics has been on the rise in recent years. That trend is continuing in 2017, with nine deals announced in the first quarter. Five of those were announced in March alone. The second quarter is off to a good start, too. Pivot Physical Therapy, a portfolio company of CI Capital Partners, just inked its fourth deal of 2017. On April 5, 2017, Pivot acquired Tidewater Physical Therapy, an outpatient physical therapy practice with more than 30 locations across Virginia, including five aquatic therapy centers and three performance centers. This purchase comes on the heels of a two-year buying spree. Back in 2014, CI Capital Partners, alongside... Read More »